Apyx Medical Corp APYX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality
-
Apyx Medical Corporation Reports Second Quarter 2026 Financial Results
-
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Trading Information
- Previous Close Price
- $2.56
- Day Range
- $2.54–2.65
- 52-Week Range
- $2.32–5.08
- Bid/Ask
- $2.55 / $2.56
- Shares Outstanding
- 42.12M
- Market Cap
- $107.42M
- Volume/Avg
- 53,987 / 129,450
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.90
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 205
- Website
- https://apyxmedical.com
Valuation
|
Metric
|
APYX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 10.27 |
Price/Sales | 1.90 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
APYX
|
|---|---|
Quick Ratio | 4.41 |
Current Ratio | 5.68 |
Interest Coverage | −0.61 |
Quick Ratio
APYX
Profitability
|
Metric
|
APYX
|
|---|---|
Return on Assets (Normalized) | −10.61% |
Return on Equity (Normalized) | −63.57% |
Return on Invested Capital (Normalized) | −5.81% |
Return on Assets
APYX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|!^KGb$S | LOCK|VX!x& | $181B | |||
| Medtronic PLC
MDT
| LOCK|<#NjNX | LOCK|%vFw | $121B | |||
| Stryker Corp
SYK
| LOCK|<s?B#j& | LOCK|Vp | $113B | |||
| Boston Scientific Corp
BSX
| LOCK|HF^%jW | LOCK|R@R& | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|>>V<Vx%# | LOCK|nk#@ | $50B | |||
| DexCom Inc
DXCM
| LOCK|gf#S@&rG | LOCK|&k^#% | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|MF^B>H | LOCK|p^f | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|TM | LOCK|<@ | $25B | |||
| Steris PLC
STE
| LOCK|hG^gPKx | LOCK|H&V<j | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|zHDjxz&T | LOCK|>j@ | $18B |
United States